Cibc Private Wealth Group, LLC Beam Therapeutics Inc. Transaction History
Cibc Private Wealth Group, LLC
- $50.1 Billion
- Q1 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 150 shares of BEAM stock, worth $3,522. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150Holding current value
$3,522% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding BEAM
# of Institutions
241Shares Held
65.6MCall Options Held
311KPut Options Held
777K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.18MShares$192 Million1.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.58MShares$178 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.71MShares$157 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.51MShares$106 Million0.7% of portfolio
-
Morgan Stanley New York, NY4.12MShares$96.8 Million0.01% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.65B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...